Work

Epirubicin versus CMF as adjuvant therapy for stage I and II breast cancer: a prospective randomised study

Year: 2002

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: European Journal of Cancer

DOI: 10.1016/s0959-8049(02)00452-5

Authors: M Colozza, G Bisagni, A.M Mosconi, S Gori, C Boni, R Sabbatini, A Frassoldati, R Passalacqua, A.Rosa Bian, C Rodinò, E Rondini, R Algeri, S Di Sarra, V De Angelis, G Cocconi, M Tonato

Institutions: Azienda Ospedaliera di Perugia, Santa Maria Nuova Hospital, University of Modena and Reggio Emilia, Ospedale di Parma, Azienda Unità Sanitaria Locale Piacenza, Ospedaliera di Piacenza, Ospedale Misericordia - Grosseto

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2002605983

FWCI: 0.88

Cites: 45

Cited by: 14

Related to: 10